Phoenix Group Holdings (the "Company")
In compliance with Listing Rule 9.6.14, the Company announces that with effect from 21 April 2015, Rene-Pierre Azria, a non-executive director of the Company, has been appointed a director of Immune Pharmaceuticals Inc, whose shares are listed in the USA on the NASDAQ.
Enquiries:
Media
Neil Bennett, Maitland
Peter Ogden, Maitland
+ 44 (0) 20 7379 5151 |
Investors
Sam Perowne, Head of Investor Relations, Phoenix Group
+44 (0) 203 735 0021 |
